SamirTanejaMD

Minimally Invasive Surgery, Surgical Oncology

James M and Janet Riha Neissa Professor of Urologic Oncology; Professor of Urology and Radiology; Director, Division of Urologic Oncology; NYU Langone Medical Center

Join to view full profile

Dr. Taneja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Taneja's full profile

Already have an account?

Office
150 E 32nd St
New York, NY 10016
Phone+1 646-825-6300

Education & Training

New York University School of MedicinePost-Doctoral Fellowship, 1996 - 1998
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1990 - 1996
Northwestern University The Feinberg School of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 1997 - 2026
NJ State Medical License 2023 - 2025
CA State Medical License 1992 - 1996
American Board of Urology Urology

Awards, Honors, & Recognition

Distinguished Contribution Award American Urological Association, 2023
America's Top Doctors Castle Connolly, 2007-2022
New York Magazine: Top Doctors Castle Connolly, 2005-2016, 2018-2022
Top Doctors: New York Metro Area Castle Connolly, 2005-2022
America's Top Doctors for Cancer Castle Connolly, 2005-2022
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer Start of enrollment: 2009 Jul 01
Completed
Phase 1, Phase 2
Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery Start of enrollment: 2011 Jun 01
Completed
Not Applicable
MRI-Targeted Focal Ablation of the Prostate in Men With Prostate Cancer Start of enrollment: 2014 Sep 01
Completed
Not Applicable
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer Start of enrollment: 2017 Oct 17
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

90 citations
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky, Bernard H. Bochner, Guido Dalbagni
Journal of Clinical Oncology. 2018-05-09
1770 citations
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan, Antti Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse
The New England Journal of Medicine. 2018-03-18
101 citations
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.
James S. Wysock, Neil Mendhiratta, Fabio Zattoni, Xiaosong Meng, Marc A. Bjurlin
BJU International. 2016-10-01

Journal Articles

The Ultrasound Characteristics of MRI Suspicious Regions Predict the Likelihood of Clinically Significant Cancer on MRI‐Ultrasound Fusion Targeted Biopsy
Samir S Taneja, Andrew B Rosenkrantz, BJU International

Press Mentions

How Can Urologic Oncology Surgeons Stay Relevant in a Rapidly Changing Field?December 14th, 2021
U.S. NEWS' BEST HOSPITALS 2018-19: MRI-Guided Prostate Therapy at NYU LangoneSeptember 12th, 2018
AUA 2018: Three Articles Last Year That Change or Influenced My PracticeMay 20th, 2018
Join now to see all